SCHEMBL2280491

SCHEMBL2280491

COc1ccc(CNc2nc(C(C)=O)cs2)c(OC)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.48
APLNR P35414 1/20 0.48
ABCB1 P08183 1/20 0.47
ALDH1A1 P00352 3/20 0.47
TSHR P16473 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MAOB P27338 1/20 0.45
PKM P14618 1/20 0.45
USP2 O75604 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3160157 0.81 APLNR (0.52) KDM4CAPLNRALDH1A1TSHRMEN1
SCHEMBL354761 0.79 APLNR (0.50) APLNRALDH1A1TSHRMEN1KMT2A
SCHEMBL12517962 0.77 KDM4C (0.51) KDM4CAPLNRALDH1A1TSHRNPSR1
SCHEMBL320510 0.73 SMN1; SMN2 (0.55) KDM4CAPLNRALDH1A1TSHRMEN1
SCHEMBL322837 0.73 GAA (0.60) KDM4CAPLNRALDH1A1TSHRMEN1
SCHEMBL30736062 0.73 KDM4C (0.60) KDM4CAPLNRALDH1A1TSHRNPSR1
SCHEMBL14921907 0.72 APLNR (0.54) KDM4CAPLNRALDH1A1TSHRMEN1
SCHEMBL10141758 0.71 APLNR (0.65) APLNRALDH1A1TSHRNPSR1HPGD
SCHEMBL29304170 0.71 RAB9A (0.61) APLNRALDH1A1TSHRNPSR1MEN1
SCHEMBL21640422 0.71 APLNR (0.52) KDM4CAPLNRALDH1A1TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130059896-A1 5-(1H-PYRAZOL-5-YL)THIAZOLE-BASED COMPOUNDS FOR THE TREATMENT OF DISEASES AND DISORDERS OF THE EYE LEXICON PHARMACEUTICALS, INC. 2013-03-07 US disclosed
WO-2011091204-A1 5-(1H-PYRAZOL-5-YL)THIAZOLE-BASED COMPOUNDS FOR THE TREATMENT OF DISEASES AND DISORDERS OF THE EYE LEXICON PHARMACEUTICALS, INC. (US) 2011-07-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130059896-A1 5-(1H-PYRAZOL-5-YL)THIAZOLE-BASED COMPOUNDS FOR THE TREATMENT OF DISEASES AND DISORDERS OF THE EYE LIMK2, LIMK1, EYA2 KDM4C 4334/4885APLNR 3882/4885ABCB1 4221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.